You are here

  • Home
  • Archive
  • Volume 89, Issue Suppl 1
  • P1.020 Phenotypic and Genetic Characterization of the First Three Cases of Extended-Spectrum Cephalosporin Resistant Neisseria Gonorrhoeae Infection in South Africa and Association with Cefixime Treatment Failure

Article Text

Article menu

Download PDFPDF

P.01 - Basic Sciences Track
P1.020 Phenotypic and Genetic Characterization of the First Three Cases of Extended-Spectrum Cephalosporin Resistant Neisseria Gonorrhoeae Infection in South Africa and Association with Cefixime Treatment Failure
Free
  1. L Y E Gumede1,
  2. M Unemo2,
  3. C Sriruttan3,
  4. D Golparian2,
  5. E E Müller1,
  6. K Rebe4,
  7. D Fick5,
  8. J de Wet6,
  9. J Coetzee3,
  10. D A Lewis1,7,8
  1. 1National I nstitute for Communicable Diseases, Johannesburg, South Africa
  2. 2WHO Collaborating Centre for Gonorrhoea and other STIs, Swedish Reference Laboratory for Pathogenic Neisseria, Örebro University Hospital, Örebro, Sweden, Örebro, Sweden
  3. 3Department of Clinical Microbiology, Ampath National Laboratory Services, Centurion, South Africa, Centurion, South Africa
  4. 4Anova Health Institute, Ivan Toms Centre for Men’s Health, Cape Town, South Africa, Cape Town, South Africa
  5. 5Meldene Medicross Clinic, Johannesburg, South Africa, Johannesburg, South Africa
  6. 6Springs Medicross Clinic, Springs, South Africa, Springs, South Africa
  7. 7Department of Internal Medicine, University of the Witwatersrand, Johannesburg, South Africa, Johannesburg, South Africa
  8. 8Division of Medical Microbiology, University of Cape Town Medical School, Cape Town, South Africa, Cape Town, South Africa

Abstract

Objectives To describe the phenotypic and genetic characteristics of the first three cases of extended-spectrum cephalosporin (ESC) resistant Neisseria gonorrhoeae in South Africa which were associated, in one case, with a verified cefixime treatment failure.

Methods Three ESC resistant N. gonorrhoeae isolates were cultured from the urethral discharge of three men-who-have-sex-with-men (MSM), two residing in Johannesburg and one in Cape Town. One of the MSM reported a persistent urethral discharge which had failed to respond to previous therapy with oral cefixime. Agar dilution minimum inhibitory concentration assays were performed for eight antibiotics. The Johannesburg patients’ isolates were further characterised by identification of key β-lactam-associated resistance mutations in penA, mtrR and its promoter, porB1b, ponA, and pilQ through PCR-based amplification and DNA sequencing .For molecular epidemiological characterisation, all three isolates were typed by N. gonorrhoeae multi-antigen sequencing typing (NG-MAST); additionally, full-length porB gene sequencing and multi-locus sequence typing (MLST) were performed for the Johannesburg isolates.

Results All three isolates were resistant to cefixime, ciprofloxacin, penicillin and tetracycline, intermediate/resistant to azithromycin but susceptible to ceftriaxone and gentamicin. The Johannesburg isolates had the type XXXIV penAmosaic allele in addition to previously described resistance mutations in the mtrR promoter (A deletion), porB1b ( penB) (G101K, A102N) and ponA1 (L421P). All three isolates had an identical N. gonorrhoeae multi-antigen sequence type (ST4822). The two Johannesburg isolates had an identical multi-locus sequence type (ST1901).

Conclusions All three strains were resistant to cefixime and were epidemiologically linked with identical NG-MAST sequence types. The Johannesburg isolates possessed a number of key β-lactam-associated resistance mutations and the type XXXIV penAmosaic allele. These two isolates belonged to a successful international MSM-linked multi-drug-resistant gonococcal clone (MLST ST1901), associated with several cefixime treatment failures in Europe and North America.

  • antimicrobials
  • bacteriology
  • surveillance

https://doi.org/10.1136/sextrans-2013-051184.0241

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.